Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021

SELL
$2.42 - $4.47 $1.5 Million - $2.77 Million
-620,402 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$2.28 - $6.84 $58,675 - $176,027
25,735 Added 4.33%
620,402 $1.43 Million
Q3 2020

Nov 13, 2020

SELL
$5.39 - $8.24 $621,375 - $949,931
-115,283 Reduced 16.24%
594,667 $3.41 Million
Q2 2020

Aug 14, 2020

SELL
$2.67 - $7.91 $283,345 - $839,425
-106,122 Reduced 13.0%
709,950 $5.23 Million
Q1 2020

May 15, 2020

SELL
$2.03 - $4.35 $104,605 - $224,155
-51,530 Reduced 5.94%
816,072 $2.43 Million
Q4 2019

Feb 18, 2020

BUY
$2.08 - $5.06 $1.8 Million - $4.39 Million
867,602 New
867,602 $3.6 Million

Others Institutions Holding OVID

About Ovid Therapeutics Inc.


  • Ticker OVID
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,419,400
  • Market Cap $51.4M
  • Description
  • Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...
More about OVID
Track This Portfolio

Track Axa S.A. Portfolio

Follow Axa S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.